International Clinical Trial: Research on Machine Learning Based on Multi-modal Radiomics for Diagnostic Decision-Making and Risk Stratification of Breast Cancer

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119290) titled 'Research on Machine Learning Based on Multi-modal Radiomics for Diagnostic Decision-Making and Risk Stratification of Breast Cancer' on Feb. 25.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Second Xiangya Hospital of CSU

Condition: breast cancer

Intervention: Gold Standard:The gold standard is the postoperative or core needle biopsy pathological diagnosis. All patients were pathologically confirmed as having either breast cancer or benign breast lesions, with pathology results independently reviewed and verified by two experienced pathologists.

Recruitment Statu...